InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by Renaud Ronald C JR, Chief Executive Officer. Insider active across 3 companies, notably Atara Biotherapeutics, Inc.. Cumulatively, 6 filings have been logged. Total volume traded: €32.4m. The latest transaction was disclosed on 14 September 2021 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
€16m503,231 shares@ €32.189899.7% of flow
Common Stock
SEC:0001209191-21-056062·
€56,1779,026 shares@ €6.22390.3% of flow
Common Stock
SEC:0001209191-21-056060·
€16m503,231 shares@ €32.189849.8% of flow
Common Stock
SEC:0001209191-21-056062:0·
€56,1779,026 shares@ €6.22390.47% mcap0.2% of flow
Common Stock
SEC:0001209191-21-056060:0·
011,000 shares0
Common Stock
SEC:0001140361-21-020441·
011,000 shares0
Common Stock
SEC:0001140361-21-020441:0·
6 of 6 declarations
About Renaud Ronald C JR
Ronald C. Renaud Jr. is the Chief Executive Officer of Atara Biotherapeutics, Inc. and Translate Bio, Inc. In these roles, he oversees the operations and growth strategy of the biopharmaceutical companies. Renaud brings extensive experience in the biotechnology sector, contributing to innovation and treatment research. His leadership is essential for achieving product development and commercialization objectives.
